Back to News

3 April 2025

Frost & Sullivan Interview – Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

Frost & Sullivan Interview – Transformational Growth Leadership: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical

Innovating for Growth: The Future of Biotech CROs

The biotech Contract Research Organization (CRO) industry is undergoing a rapid transformation, driven by technological advancements, globalization, and evolving patient needs. In this exclusive interview, Yvonne Lungershausen, CEO of Avance Clinical, shares how her company is leading this change—leveraging AI, expanding globally, and prioritizing patient engagement to accelerate clinical trials. Join us as we explore the future of biotech CROs and what it takes to stay ahead in this competitive landscape.

Read the full article

Related Articles

Korea University Medicine, Taiwan Alliance of Clinical Trial Centers, and Avance Clinical Convene Regional Collaboration Event in Seoul

29 July 2026

Korea University Medicine, Taiwan Alliance of Clinical Trial Centers, and Avance Clinical Convene Regional Collaboration Event in Seoul

Korea University Medicine, TACTC and Avance Clinical met in Seoul to strengthen Asia-Pacific clinical research and drug development partnerships.

Read more
Avance Clinical and Dongguk University Establish Strategic Partnership to Develop Future Clinical Research Talent

21 July 2026

Avance Clinical and Dongguk University Establish Strategic Partnership to Develop Future Clinical Research Talent

Dongguk University and Avance Clinical sign an MOU to strengthen industry-academia collaboration and develop future pharma and biotech talent.

Read more
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026

10 July 2026

Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026

Global CRO highlights multi-regional trial delivery, early-phase Australia advantages, and expanding support for biotech sponsors across Asia and China.

Read more
Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026

22 June 2026

Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026

Global CRO expands its operational footprint into Singapore and Malaysia, strengthens China presence, and grows India operations - creating a powerhouse in the Asia Pacific region.

Read more
Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026

19 May 2026

Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026

Avance Clinical will engage with biotech sponsors to discuss strategies for delivering efficient, high-quality oncology trials spanning first-in-human through to later-phase proof of concept global programs.

Read more
Frost & Sullivan’s 2026 Global Company of the Year

12 May 2026

Frost & Sullivan’s 2026 Global Company of the Year

Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.

Read more
Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence

18 March 2026

Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence

Avance Clinical, a global full-service CRO headquartered in Australia dedicated to servicing biotech, announces the appointment of Liahna Toy as Senior Vice President & Head of Early Phase Center of Excellence, reinforcing the company’s strategic focus on accelerating high-quality early-phase trials for emerging biotech sponsors.

Read more
Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S-Based LumaBridge

7 January 2026

Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S-Based LumaBridge

Avance Clinical today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials.

Read more
Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America

6 November 2025

Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America

Avance Clinical has announced the launch of its new Diversity in STEM Scholarships.

Read more
Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna

3 November 2025

Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna

Helping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower Costs, and Globally Accepted Data

Read more
Avance Clinical Launches Renal and Cardiometabolic Center of Excellence to Optimize Patient Recruitment to Elevate Study Success

30 October 2025

Avance Clinical Launches Renal and Cardiometabolic Center of Excellence to Optimize Patient Recruitment to Elevate Study Success

Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence.

Read more
Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience

28 October 2025

Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience

Avance Clinical announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.

Read more